In addition, GLP-1 medications have shown positive results in other critical health indicators, and the FDA has approved its use to reduce the risk of serious heart problems, specifically in obese or overweight patients
Two 10-year case-control studies over very large samples of people with diabetes ( N = 360,205 and N = 73,869, respectively) equally observed no association between GLP-1RA use and incident depression 202,203
Its about offering an experience that connects medical consultation, follow-up care, and lifestyle management
Step 2 Remove the protective cap
L., Chen, C
The results showed that each intervention, whether diet restriction, gastric bypass surgery (RYGB), or medications like tirzepatide and semaglutide, had different impacts on the bodys physiological response to weight loss